Novartis

Interested in learning
more about expert
clinical insights into

AML &  
ADVANCED SM?

The promotional event is for HCPs licensed to
practice medicine in the E.U. only.


AML, acute myeloid leukaemia; SM, systemic mastocytosis.

Join renowned experts for a

VIRTUAL PANEL AND Q&A

to further explore these diseases &
treatment with targeted therapy

Prof. Richard Schlenk
Head of Clinical Trials Center
National Center for Tumor Diseases
Heidelberg, Germany

Dr. Deepti Radia
Guy's and St. Thomas's
NHS Foundation Trust
London, UK

LEARN
MORE ABOUT
AML &
ADVANCED SM

REGISTER NOW